Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ACSVL3 Inhibitors

ACSVL3 inhibitors are a class of chemical compounds or molecules designed to target and modulate the activity of the acyl-CoA synthetase very long-chain family member 3 (ACSVL3) protein. ACSVL3 is an enzyme that plays a vital role in cellular lipid metabolism, particularly in the activation of very long-chain fatty acids by conjugating them with coenzyme A (CoA), a crucial step in the biosynthesis of various lipid molecules. The inhibition of ACSVL3 is a focus of research aimed at elucidating its functions and roles in lipid homeostasis, lipid membrane composition, and other cellular processes where lipid metabolism is crucial. ACSVL3 inhibitors are developed using a variety of chemical synthesis and structural optimization methods, with the aim of specifically interacting with the ACSVL3 protein and modulating its enzymatic activity.

The design of ACSVL3 inhibitors typically involves creating molecules that can selectively bind to ACSVL3, thus disrupting its ability to catalyze the formation of acyl-CoA compounds. These inhibitors may target specific regions of the ACSVL3 protein, such as its active site or regulatory domains, to interfere with its enzymatic function. By modulating ACSVL3 activity, these inhibitors can provide valuable insights into the roles played by ACSVL3 in cellular lipid metabolism, membrane composition, and other cellular functions dependent on lipid biology. The study of ACSVL3 inhibitors contributes to our understanding of the complex mechanisms underlying lipid metabolism and its regulation within cells. This research helps researchers unravel the intricate molecular pathways involved in lipid biology, paving the way for further investigations into the broader implications of ACSVL3 in cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lipase Inhibitor, THL

96829-58-2sc-203108
50 mg
$51.00
7
(1)

A lipase inhibitor, orlistat might influence lipid metabolism pathways, potentially affecting the expression of enzymes like ACSVL3.

Fenofibrate

49562-28-9sc-204751
5 g
$40.00
9
(1)

As a PPARα agonist, fenofibrate affects lipid metabolism and could influence the expression of lipid-metabolizing enzymes.

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$65.00
$262.00
2
(2)

Another fibrate, gemfibrozil modulates lipid levels and might indirectly affect the expression of enzymes in lipid metabolism.

Rosuvastatin

287714-41-4sc-481834
10 mg
$142.00
8
(0)

A statin that inhibits HMG-CoA reductase, rosiglitazone could indirectly influence lipid metabolism and ACSVL3 expression.

Ezetimibe

163222-33-1sc-205690
sc-205690A
25 mg
100 mg
$94.00
$236.00
12
(2)

By inhibiting cholesterol absorption, ezetimibe might impact lipid metabolism pathways, potentially affecting ACSVL3 expression.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$54.00
$123.00
13
(1)

A PPARγ agonist, pioglitazone affects lipid and glucose metabolism, which might influence ACSVL3 expression.

Clofibrate

637-07-0sc-200721
1 g
$32.00
(1)

An older class of lipid-lowering agent, clofibrate affects lipid metabolism and could impact the expression of enzymes like ACSVL3.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$28.00
$88.00
$332.00
12
(1)

As a statin, lovastatin inhibits cholesterol synthesis, which might indirectly affect lipid metabolism and ACSVL3 expression.

CHOLESTYRAMINE RESIN

11041-12-6sc-507509
5 g
$210.00
(0)

A bile acid sequestrant, cholestyramine affects cholesterol metabolism, potentially impacting ACSVL3 expression.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$252.00
$495.00
9
(1)

Another statin, atorvastatin lowers cholesterol levels and might indirectly influence the expression of enzymes in lipid metabolism.